Podcast appearances and mentions of joel stanley

Joel Stanley is the CEO of Ajna Biosciences, a company developing the next generation of botanical medicines. These full-spectrum drugs, derived from plants and fungi, are regulated and approved through the FDA, unlike dietary supplements. Lead drug candidates are targeting autism, generalized anxiety disorder, and PTSD. With expertise in cultivating and scaling the production of botanical raw materials, Ajna is creating a sustainable model compared to wild-harvested botanicals. Joel explains, "It's no secret that before about a hundred years ago, all of our medicines were botanical medicines, or mostly coming from plants, or maybe mushrooms. And in the last century, as we developed Western medicine - modern medicine - the drug approval process started to learn how to synthesize molecules and isolate molecules from nature. So we started to step completely away from plant medicine and into a synthetic pharmaceutical landscape. The FDA fairly recently started allowing botanical drugs. So what that means is that it's full-spectrum medicines coming from the given root, shrub, leaf, flower, or mushroom. Those would be botanical drugs. So botanical drugs are not single-compound botanically derived drugs, which make up about 20% of our pharmaceuticals. They're a full-spectrum plant extract, a botanical drug from a regulatory standpoint." "So, plant-based therapeutics can mean dietary supplements that do not go through clinical trials. They're not legally prescribed by doctors and generally not covered by insurance. Whereas botanical drugs go through the FDA drug approval process, rigorous clinical trials against placebo control to become FDA approved, covered by insurance, and legally prescribable. So that's really what sets what we're doing, creating botanical drugs, apart from what people have considered plant medicine this last century." "Our most advanced drug in our pipeline is called AJA001, and it's very special to me because I've been basically working on this drug for more than 15 years. It's made in partnership with my previous company. I was the first CEO of a company called Charlotte's Web, which was really the first, and it's still the largest CBD brand out there. It was everything we learned at Charlotte's Web that kind of prompted me to start Ajna BioSciences four years ago. And that first drug is made from full-spectrum hemp, so it is CBD dominant, and it does have other cannabinoids, such as THC, as well as other minor cannabinoids. It also has certain terpenes."  #AjnaBiosciences #BotanicalMedicine #PlantBasedTherapeutics #PharmaInnovation #DrugDevelopment #NaturalMedicine #BioTech ajnabiosciences.com Download the transcript here

Joel Stanley is the CEO of Ajna Biosciences, a company developing the next generation of botanical medicines. These full-spectrum drugs, derived from plants and fungi, are regulated and approved through the FDA, unlike dietary supplements. Lead drug candidates are targeting autism, generalized anxiety disorder, and PTSD. With expertise in cultivating and scaling the production of botanical raw materials, Ajna is creating a sustainable model compared to wild-harvested botanicals. Joel explains, "It's no secret that before about a hundred years ago, all of our medicines were botanical medicines, or mostly coming from plants, or maybe mushrooms. And in the last century, as we developed Western medicine - modern medicine - the drug approval process started to learn how to synthesize molecules and isolate molecules from nature. So we started to step completely away from plant medicine and into a synthetic pharmaceutical landscape. The FDA fairly recently started allowing botanical drugs. So what that means is that it's full-spectrum medicines coming from the given root, shrub, leaf, flower, or mushroom. Those would be botanical drugs. So botanical drugs are not single-compound botanically derived drugs, which make up about 20% of our pharmaceuticals. They're a full-spectrum plant extract, a botanical drug from a regulatory standpoint." "So, plant-based therapeutics can mean dietary supplements that do not go through clinical trials. They're not legally prescribed by doctors and generally not covered by insurance. Whereas botanical drugs go through the FDA drug approval process, rigorous clinical trials against placebo control to become FDA approved, covered by insurance, and legally prescribable. So that's really what sets what we're doing, creating botanical drugs, apart from what people have considered plant medicine this last century." "Our most advanced drug in our pipeline is called AJA001, and it's very special to me because I've been basically working on this drug for more than 15 years. It's made in partnership with my previous company. I was the first CEO of a company called Charlotte's Web, which was really the first, and it's still the largest CBD brand out there. It was everything we learned at Charlotte's Web that kind of prompted me to start Ajna BioSciences four years ago. And that first drug is made from full-spectrum hemp, so it is CBD dominant, and it does have other cannabinoids, such as THC, as well as other minor cannabinoids. It also has certain terpenes."  #AjnaBiosciences #BotanicalMedicine #PlantBasedTherapeutics #PharmaInnovation #DrugDevelopment #NaturalMedicine #BioTech ajnabiosciences.com Listen to the podcast here

In this Roofing Road Trips® episode, Heidi J. Ellsworth chats with Joel Stanley, founder and CEO of Anchor Products, about his passion for creating solutions for the roofing industry. He is the inventor of the U-Anchor and all its rooftop securement solutions. Growing up in the roofing industry, followed by decades of experience in the commercial roofing industry, he has created roofing solutions that have resulted in 26 patents. They talk about his passion for educating the industry on current and future rooftop solutions and how his experience in roofing with his family continues to help him provide solutions for rooftop challenges.    Learn more at RoofersCoffeeShop.com!  https://www.rooferscoffeeshop.com/     Are you a contractor looking for resources? Become an R-Club Member today! https://www.rooferscoffeeshop.com/rcs-club-sign-up     Sign up for the Week in Roofing!  https://www.rooferscoffeeshop.com/sign-up     Follow Us!   https://www.facebook.com/rooferscoffeeshop/   https://www.linkedin.com/company/rooferscoffeeshop-com   https://x.com/RoofCoffeeShop   https://www.instagram.com/rooferscoffeeshop/   https://www.youtube.com/channel/UCAQTC5U3FL9M-_wcRiEEyvw   https://www.pinterest.com/rcscom/   https://www.tiktok.com/@rooferscoffeeshop   https://www.rooferscoffeeshop.com/rss     #RoofersCoffeeShop #MetalCoffeeShop #AskARoofer #CoatingsCoffeeShop #RoofingProfessionals #RoofingContractors #RoofingIndustry #AnchorProducts

In this episode, Chris is joined by Joel Stanley, CEO of AJNA BioSciences. Joel discusses his transition from co-founding Charlotte's Web, a pioneer in the CBD industry, to establishing AJNA BioSciences. He shares the powerful backstory of how his work with CBD began, notably with Charlotte Figi, a young girl whose severe seizures were dramatically reduced using a CBD-rich extract. This episode gets into AJNA BioSciences' mission to integrate plant-based medicines with modern pharmaceutical practices, emphasizing their current focus on developing botanical drugs for conditions like autism spectrum disorder and anxiety through rigorous FDA-approved clinical trials.Highlights include…Creating FDA-approved drugs from plant medicine for treating conditions like autism and anxiety.The decline of plant medicine and its potential revival through modern technology and regulatory changes. (3:53)Developing botanical drugs for autism and anxiety disorders, progress and challenges in clinical trials. (8:25)Fundraising for Arjuna Biosciences, a biotech company developing cannabinoid-based drugs. (16:16)Developing cannabis-based drugs for various diseases, including PTSD and sleep disorders. (20:44)

Welcome to The Green Rush, a podcast about the intersection of cannabis, the capital markets, and culture. On a weekly basis, hosts Anne Donohoe and Nick Opich of KCSA Strategic Communications speak with the business leaders, financial experts, cultural icons, legislators, and generally interesting people moving the cannabis and psychedelics industries forward. Very few companies in this space need no introduction - and Charlotte's Web - is one of them.  Today Anne and guest host Phil Carlson speak with two of the seven Stanley brothers, Jesse and Joel, both pioneers in CBD - and who's CBD-rich hemp genetics changed marijuana history. Their strain, named for Charlotte Figi, a young girl who lived with as many as 300 epileptic seizures a day and who was the feature of the groundbreaking 2013 piece by CNN's Sajjay Gupta called “Weed.”  Through the use of the hemp genetics developed by the Stanley Brothers, Figi experienced an immediate reduction in her epileptic seizures down to just two or three per month. She became some of the most prominent figures in the legalization movement before sadly passing away in 2020 at the age of 13. In this episode, Anne and Phil talk to the brothers about the history of Charlotte's Web, what it's like working with so much of their family, and their insights into what's next for the company.  So sit back and enjoy our conversation with Jesse and Joel Stanley, co-founders of Charlotte's Web. Links and mentions in the show https://www.charlottesweb.com/  Links to the guest's company and social media accounts Charlotte's Web Twitter: https://twitter.com/charlottesweb Charlotte's Web Facebook: https://www.facebook.com/CharlottesWebCBD/ Charlotte's Web Instagram: https://www.instagram.com/charlotteswebcbd/ Jesse Stanley's LinkedIn: https://www.linkedin.com/in/jessemstanley/ Joel Stanley's LinkedIn: https://www.linkedin.com/in/joel-stanley-2885116b/  Show Credits: This episode was hosted by Anne Donohoe and Phil Carlson of KCSA Strategic Communications.  Special thanks to our Program Director Shea Gunther. You can learn more about how KCSA Cannabis can help your cannabiz by visiting www.kcsa-cannabis.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels: Twitter: @The_GreenRush  Instagram: @thegreenrush_podcast LinkedIn: https://www.linkedin.com/company/thegreenrushpodcast/  Facebook: https://www.facebook.com/TheGreenRushPodcast/  YouTube: https://www.youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

Joel Stanley and the Birth of the CBD Industry Episode Resources:Host: Jonathan MillerGuest: Joel StanleyBlog: Hemp Legally SpeakingHemp Industry questions covered in this episode: Who was Charlotte Fygi, and what role did she play in the development of the hemp and CBD industries? When did medical marijuana pioneers, the Stanley Brothers, hit on the idea that hemp could be a solution both for ailing children as well as promoting wellness in healthy adults? What was behind the Stanleys' decision to take Charlotte's Web public, and how should we assess the progress? What's on the immediate horizon for the Stanleys in the health and wellness space?

CBD mania is in full swing and people are using it for just about anything, but did you know CBD's unlikely origin story? We speak to Paige Figi and Josh and Joel Stanley about their medical CBD discovery.  Learn more about your ad choices. Visit podcastchoices.com/adchoices

The initiative to provide high standards in our industry. Today, we are joined by Marielle Weintraub. She is the Strategic Business Development Director for the Hemp Initiative at Eurofins Food Integrity and Innovation, formerly Covance Food Solutions. She is a founding board member and the current President for the US Hemp Authority and we are going to talk about an announcement recently made by the Hemp Authority. The actual certification program is the initiative to provide high standards in our industry. The U.S. Hemp Authority Certified Seal program was established in 2018 and funded by the U.S. Hemp Roundtable. It was developed with guidance from David Bossman, a founding member of AgWin Group, and collaborators include the Hemp Industries Association, state pilot project participants, industry-leading firms, top-tier testing laboratories, and quality assessors. Joel Stanley, chairman of Charlotte’s Web, had been collaborating with the Hemp Authority to create the quality standards. We talk about how much work it took to get all these great minds in the hemp space to come together and find an ultimate consensus. as well as how far she thinks the gap is on people distinguishing hemp from the stigma that came more from cannabis and how hemp got attached to it.

The initiative to provide high standards in our industry. Today, we are joined by Marielle Weintraub. She is the Strategic Business Development Director for the Hemp Initiative at Eurofins Food Integrity and Innovation, formerly Covance Food Solutions. She is a founding board member and the current President for the US Hemp Authority and we are going to talk about an announcement recently made by the Hemp Authority. The actual certification program is the initiative to provide high standards in our industry. The U.S. Hemp Authority Certified Seal program was established in 2018 and funded by the U.S. Hemp Roundtable. It was developed with guidance from David Bossman, a founding member of AgWin Group, and collaborators include the Hemp Industries Association, state pilot project participants, industry-leading firms, top-tier testing laboratories, and quality assessors. Joel Stanley, chairman of Charlotte’s Web, had been collaborating with the Hemp Authority to create the quality standards. We talk about how much work it took to get all these great minds in the hemp space to come together and find an ultimate consensus. as well as how far she thinks the gap is on people distinguishing hemp from the stigma that came more from cannabis and how hemp got attached to it.

CBD mania is in full swing and people are using it for just about anything, but what is this chemical in cannabis? In this week’s episode, we tell you unlikely origin story of CBD and if the science backs up the hype. We speak to Paige Figi, neuroscientist Prof. Kent Hutchison, clinical researcher Dr. Mallory Loflin, and Josh and Joel Stanley. Check out the transcript right here: http://bit.ly/2OVCfub Selected references: Mallory’s study showing most CBD products are labeled inaccurately and 1 out of 5 has some THCReview discussing all the possible things CBD is binding to in the brainNational Academy of Sciences report on cannabis and cannabinoids Clinical trial showing CBD reduces seizures for treatment-resistant epilepsy  Credits: This episode was produced by Kaitlyn Sawrey with help from Wendy Zukerman, along with Rose Rimler, Meryl Horn and Odelia Rubin. We’re edited by Blythe Terrell, with help from Caitlin Kenny. Fact checking by Michelle Harris. Mix and sound design by Emma Munger. Music by Emma Munger and Bobby Lord. A huge thanks to Professor Elizabeth Thiele, Professor Cinnamon Bidwell, Professor Celia Morgan, Associate Professor Ziva Cooper, and Associate Professor Didier Jutras-Aswad, as well as Sindu Gnanasambandan, Mathilde Urfalino, Frank Lopez, Joseph Lavelle Wilson and the Zukerman Family.

We continue our exploration of Burning Man and potential connections to re-imagining Judaism with an interview with Joel Stanley, who serves as Senior Director of House Programs at Moishe House. Joel has attended Burning Man every year for over a decade. Joel joins Dan and Lex to explore the ways in which Jewish organizations may be able to learn from Burning Man, as well as some of the ways he has sought to do that work in his own context of Moishe House. If you're enjoying Judaism Unbound, please help us keep things going with a one-time or monthly tax-deductible donation. Support Judaism Unbound by clicking here. To access full shownotes for this episode, click here!

Joel Stanley, the CEO of CW Hemp, joins us on the THINKING Podcast to discuss the origins of his family-run CBD company, the state of the rapidly growing industry, and how his CBD product can be used for biohacking. The inception of his company is especially interesting. CW Hemp breeds high CBD plants, the cannabinoid substance in cannabis and hemp that is non-psychoactive (by having very little THC) but maintains documented medicinal benefits, known for its anti-anxiety and anticonvulsant effects. Their flagship product was used to stop Charlotte's epileptic seizures, a little girl who had gone through every other medical procedure to no avail. Her usage of the product was featured in a CNN documentary and garnered national media coverage, and the product was then named after her. Since then, CW Hemp not only provides biohackers with a product that can protect the brain but also continues to be a beacon of hope for parents with children in similar situations.   SUBSCRIBE for weekly episodes that will make you THINK!

Joel Stanley, the CEO of CW Hemp, joins us on the THINKING Podcast to discuss the origins of his family-run CBD company, the state of the rapidly growing industry, and how his CBD product can be used for biohacking. The inception of his company is especially interesting. CW Hemp breeds high CBD plants, the cannabinoid substance in cannabis and hemp that is non-psychoactive (by having very little THC) but maintains documented medicinal benefits, known for its anti-anxiety and anticonvulsant effects. Their flagship product was used to stop Charlotte's epileptic seizures, a little girl who had gone through every other medical procedure to no avail. Her usage of the product was featured in a CNN documentary and garnered national media coverage, and the product was then named after her. Since then, CW Hemp not only provides biohackers with a product that can protect the brain but also continues to be a beacon of hope for parents with children in similar situations.   SUBSCRIBE for weekly episodes that will make you THINK!

Why you should listen - Is Cannabis the new wonder drug? Dave aims to find out if it is as he sits down with CW Hemp founder Joel Stanley to talk about getting healthy instead of high with world's oldest domesticated crops. Joel reveals how Cannabinoids, one of the compounds found in Hemp, has been found to have potent antioxidant and neuroprotective properties. Scientist are currently studying Cannabinoids and their potential to create revolutionary and life saving treatments for neuroinflammation, epilepsy, oxidative injury, sleep disorders, anxiety and schizophrenia.

Why you should listen - Is Cannabis the new wonder drug? Dave aims to find out if it is as he sits down with CW Hemp founder Joel Stanley to talk about getting healthy instead of high with world's oldest domesticated crops. Joel reveals how Cannabinoids, one of the compounds found in Hemp, has been found to have potent antioxidant and neuroprotective properties. Scientist are currently studying Cannabinoids and their potential to create revolutionary and life saving treatments for neuroinflammation, epilepsy, oxidative injury, sleep disorders, anxiety and schizophrenia.

Cannabinol has been making headlines and subsequently causing Doctors to take a look at it’s potential benefits. The feedback has been profound. Education and testimonials are helping to fight the stigma surrounding the Hemp plant, especially since it has so many potential medicinal benefits. All of this is obtainable without using THC component of the plant. Show Topics Hemp Dr. Sanjay Gupta CBD Oil Not all Hemp products get you high FDA / Legal Charlotte Figi CNN Documentary Realm of Caring Foundation Data & Research Quality control & consistency Everyday Plus US Patent Hope for Dementia? EM Fields Why would you take this? Looking forward Where do you see CW in 5 Years? Stigma of Hemp Joel Stanley CW Hemp www.cwhemp.com

Today on Hempire Dr. Mitch Earleywine welcomes back Joel Stanley, Founder of CW Hemp to discuss the possible avenues of cannabis development. A great debate is emerging around whether naturally occurring cannabinoids found in the cannabis plant should be developed as pharmaceutical drugs or dietary supplements. Just how far will special interests go to control these compounds in the cannabis plant? CW Hemp is a Colorado family-owned business & exclusive provider of Charlotte’s Web™, the World’s Most Trusted Hemp Extract™. They believe in Quality, Purity, Integrity & Giving Back. CW Hemp's products have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Today on Hempire Dr. Mitch Earleywine welcomes back Joel Stanley, Founder of CW Hemp to discuss the possible avenues of cannabis development.A great debate is emerging around whether naturally occurring cannabinoids found in the cannabis plant should be developed as pharmaceutical drugs or dietary supplements. Just how far will special interests go to control these compounds in the cannabis plant?CW Hemp is a Colorado family-owned business & exclusive provider of Charlotte's Web™, the World's Most Trusted Hemp Extract™. They believe in Quality, Purity, Integrity & Giving Back. CW Hemp's products have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Today on Hempire Dr. Mitch Earleywine welcomes back Joel Stanley, Founder of CW Hemp to discuss the possible avenues of cannabis development.A great debate is emerging around whether naturally occurring cannabinoids found in the cannabis plant should be developed as pharmaceutical drugs or dietary supplements. Just how far will special interests go to control these compounds in the cannabis plant?CW Hemp is a Colorado family-owned business & exclusive provider of Charlotte's Web™, the World's Most Trusted Hemp Extract™. They believe in Quality, Purity, Integrity & Giving Back. CW Hemp's products have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy